Drug Profile
Research programme: women's health therapeutics - Crucell/Ferring
Latest Information Update: 22 Feb 2010
Price :
$50
*
At a glance
- Originator Crucell
- Class Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female genital diseases
Most Recent Events
- 22 Feb 2010 Discontinued - Preclinical for Gynaecological disorders in Denmark (unspecified route)
- 22 Feb 2010 Discontinued - Preclinical for Gynaecological disorders in Netherlands (unspecified route)
- 31 May 2005 Preclinical trials in Gynaecological disorders in Denmark (unspecified route)